Honeybees in the Garden Become a beekeeper and watch

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone Shalom Star #7161

Honeybees in the Garden

Become a beekeeper and watch your bee-friendly garden flourish.


Two bees visit this pink dahlia flower.

When it comes to your garden, you’ve always had a good Plan A; and a halfway decent Plan B. But without Plan Bee, you might as well throw away the seeds and burst any thought bubbles that include hauling a huge basketful of fruits and vegetables out of the garden come summertime.

You really have to wonder what a dinosaur thought, some 130 million years ago, when confronted by a honeybee.

Maybe he was glad he had a thick hide because, really, what kind of threat is a stinger on dino-hide? He might’ve batted the bug away, but he should’ve been more careful. Much like some mammals developed hooves and horns, bees evolved with bodies to help them do what bees do better than most any other creature on the planet: pollinate plants. Dinosaurs eventually went extinct, but it didn’t take long for the proficient pollinators to migrate all over Africa and the Eurasian landmass.

You can almost imagine how humans stumbled upon the other thing bees do: Chances are, they saw some rascally animal raid the hive and figured that sticky stuff had to be pretty tasty. Rock art in Africa and Spain shows that early humans knew how to hunt honey, Ice Age humans knew that smoke calmed bees, and Egyptians learned to keep bees in central locations. Many moons later, bees were brought to North America by beekeepers looking to relocate both home and hive.

Much like a miniature castle of old, each beehive centers on a queen. Despite the fact that most of the 50,000 to 200,000 bees in the hive are female, she is the only one allowed to lay eggs. The queen is pampered and fed and required to do no worker-bee drudgery. She doesn’t even have to take care of any squalling brat-bees. In fact, when there become too many mouths to feed, she swarms and flies off with some of her retinue — but not before allowing at least one of her eggs to become a new queen with a new colony. That new queen will ruthlessly kill all other newborn queens in the hive until she, alone, is left to rule. Unlike her subjects, the queen bee can use her stinger over and over without being killed by its use.

Indeed, it’s good to be queen

When it’s time for a queen bee to mate, she leaves the hive — one of the few times in her life that she does so — with the drones, or male bees, in hot pursuit of her Highness. She mates over and over in midair, and then flies back to the colony able to lay fertile eggs throughout her lifetime. The male bees, having lived a mere week and having done their only duty in life, then die, which proves that it’s a drone to be a drone.

Of her eggs — and a queen bee can lay a million eggs in her lifetime — the vast majority will become female worker bees.

Although a hive lives and dies for its queen, worker bees are an absolute necessity for honey-making and bee birthing. There are, in fact, many jobs within the hive, and worker bees graduate from job to job based on their age. Experienced worker bees forage for nectar, pollen and water, while younger bees work to make the wax combs and to process the nectar to make honey. There are attendants to the queen, as well as nurse bees, housekeepers, and even bees that work as little bee funeral directors. Still others tend to the queen’s eggs because, when she’s ready for retirement, they’ll have to start feeding the heir apparent, and the cycle begins again.

Page: 1 | 2 | Next >>




Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading